Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations.

Camelo Castillo W, Heath N, Kim J, Yang K, Ritchey ME, dosReis S, Santanello N, West SL.

Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):766-776. doi: 10.1002/pds.4786. Epub 2019 May 2.

PMID:
31050092
2.

Qualitative analysis and reproducibility assessment of the Scalp Itch Numeric Rating Scale among patients with moderate to severe plaque psoriasis of the scalp.

Wang Y, Coyne K, Sofen H, Santanello N, Currie B, Zhang Z, Nograles K.

J Dermatolog Treat. 2019 Mar 5:1-9. doi: 10.1080/09546634.2019.1577546. [Epub ahead of print]

PMID:
30747550
3.

Sensitivity analysis of methods for active surveillance of acute myocardial infarction using electronic databases.

Li X, Girman CJ, Ofner S, Shen C, Brodovicz KG, Simonaitis L, Santanello N.

Epidemiology. 2015 Jan;26(1):130-2. doi: 10.1097/EDE.0000000000000206.

PMID:
25390030
4.

Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.

Norquist JM, Girman C, Fehnel S, DeMuro-Mercon C, Santanello N.

Qual Life Res. 2012 Aug;21(6):1013-20. doi: 10.1007/s11136-011-0003-8. Epub 2011 Sep 10.

PMID:
21909804
5.

Migraine and cardiovascular disease: a population-based study.

Bigal ME, Kurth T, Santanello N, Buse D, Golden W, Robbins M, Lipton RB.

Neurology. 2010 Feb 23;74(8):628-35. doi: 10.1212/WNL.0b013e3181d0cc8b. Epub 2010 Feb 10.

6.

Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team.

Crowe BJ, Xia HA, Berlin JA, Watson DJ, Shi H, Lin SL, Kuebler J, Schriver RC, Santanello NC, Rochester G, Porter JB, Oster M, Mehrotra DV, Li Z, King EC, Harpur ES, Hall DB.

Clin Trials. 2009 Oct;6(5):430-40. doi: 10.1177/1740774509344101.

PMID:
19846894
7.

Migraine and cardiovascular disease: possible mechanisms of interaction.

Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB.

Neurology. 2009 May 26;72(21):1864-71. doi: 10.1212/WNL.0b013e3181a71220. Review.

8.

Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior.

Hu H, Kurth T, Cady R, Santanello N, Bigal ME.

Headache. 2009 Feb;49 Suppl 1:S34-42. doi: 10.1111/j.1526-4610.2008.01337.x. Review.

PMID:
19161564
9.

Interpreting and reporting results based on patient-reported outcomes.

Revicki DA, Erickson PA, Sloan JA, Dueck A, Guess H, Santanello NC; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.

Value Health. 2007 Nov-Dec;10 Suppl 2:S116-24.

10.

Analysis and interpretation of results based on patient-reported outcomes.

Sloan JA, Dueck AC, Erickson PA, Guess H, Revicki DA, Santanello NC; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.

Value Health. 2007 Nov-Dec;10 Suppl 2:S106-15.

11.

Validation of a questionnaire to assess niacin-induced cutaneous flushing.

Norquist JM, Watson DJ, Yu Q, Paolini JF, McQuarrie K, Santanello NC.

Curr Med Res Opin. 2007 Jul;23(7):1549-60.

PMID:
17559750
12.

Increase in nonfatal digestive perforations and haemorrhages following introduction of selective NSAIDs: a public health concern.

Watson DJ, Rahme E, Santanello NC.

Drug Saf. 2007;30(1):89-90; author reply 90-1. No abstract available.

PMID:
17194174
13.

Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis.

Santanello NC, DeMuro-Mercon C, Shah SR, Schenkel EJ, Ratner PH, Dass SB, Norquist JM, Philip G.

Allergy Asthma Proc. 2006 May-Jun;27(3):231-9.

PMID:
16913266
14.

Observational studies and the withdrawal of rofecoxib.

Watson DJ, Santanello NC.

Pharmacoepidemiol Drug Saf. 2006 Mar;15(3):199-201; author reply 203-5. No abstract available.

PMID:
16508998
15.

Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.

Meltzer EO, Philip G, Weinstein SF, LaForce CF, Malice MP, Dass SB, Santanello NC, Reiss TF.

Am J Rhinol. 2005 Nov-Dec;19(6):591-8.

PMID:
16402647
16.

Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.

Fiore M, Shields KE, Santanello N, Goldberg MR.

Cephalalgia. 2005 Sep;25(9):685-8.

PMID:
16109049
17.

Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis.

Santanello NC, Norquist JM, Nelsen LM, Williams VS, Hill CD, Bisgaard H.

Pediatr Pulmonol. 2005 Jul;40(1):31-8.

PMID:
15858804
18.

Some considerations for the interpretation of health-related quality of life data.

Norquist JM, Girman CJ, Santanello NC.

Value Health. 2005 Jan-Feb;8(1):80-1. No abstract available.

19.

The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.

Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL.

Clin Ther. 2004 Nov;26(11):1895-904.

PMID:
15639701
20.

Response to montelukast among subgroups of children aged 2 to 14 years with asthma.

Meyer KA, Arduino JM, Santanello NC, Knorr BA, Bisgaard H.

J Allergy Clin Immunol. 2003 Apr;111(4):757-62.

PMID:
12704354
21.

Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data.

Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, Nelsen LM.

J Asthma. 2003 Feb;40(1):93-101.

PMID:
12699217
22.

Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data.

Allen-Ramey FC, Duong PT, Goodman DC, Sajjan SG, Nelsen LM, Santanello NC, Markson LE.

Allergy Asthma Proc. 2003 Jan-Feb;24(1):43-51.

PMID:
12635577
23.

Determinants of migraine-specific quality of life.

Santanello NC, Davies G, Allen C, Kramer M, Lipton R.

Cephalalgia. 2002 Oct;22(8):680-5.

PMID:
12383065
24.

Regulatory issues for health-related quality of life--PhRMA Health Outcomes Committee workshop, 1999.

Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, Gagnon JP, Hsuan A, Jackson J, Mahmoud R, Miller D, Morgan M, Osterhaus J, Tilson H, Willke R.

Value Health. 2002 Jan-Feb;5(1):14-25.

25.

Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.

Gerth WC, McCarroll KA, Santanello NC, Vandormael K, Zhang Q, Mannix LK.

Int J Clin Pract. 2001 Oct;55(8):552-6.

PMID:
11695077
26.

Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.

Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L; Rizatriptan Protocol 060 Study Group.

Headache. 2001 Sep;41(8):745-53.

PMID:
11576197
27.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
28.

Pediatric asthma assessment: validation of 2 symptom diaries.

Santanello NC.

J Allergy Clin Immunol. 2001 May;107(5 Suppl):S465-72. Review.

PMID:
11344376
29.

The multinational impact of migraine symptoms on healthcare utilisation and work loss.

Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC.

Pharmacoeconomics. 2001;19(2):197-206.

PMID:
11284383
30.

Development of a brief 24-hour adolescent migraine functioning questionnaire.

Hartmaier SL, DeMuro-Mercon C, Linder S, Winner P, Santanello NC.

Headache. 2001 Feb;41(2):150-6.

PMID:
11251699
31.

Work and productivity loss in the rizatriptan multiple attack study.

Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer.

Cephalalgia. 2000 Nov;20(9):830-4.

PMID:
11167913
32.

Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.

Cowley AJ, Wiens BL, Segal R, Rich MW, Santanello NC, Dasbach EJ, Pitt B; ELITE Investigators. Evaluation of Losartan in the Elderly.

Qual Life Res. 2000;9(4):377-84.

PMID:
11131930
33.

Impact of migraine and migraine therapy on productivity and quality of life.

Solomon GD, Santanello N.

Neurology. 2000;55(9 Suppl 2):S29-35. Review.

PMID:
11089517
34.

Validation of a pediatric asthma caregiver diary.

Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, Knorr B.

J Allergy Clin Immunol. 2000 Nov;106(5):861-6.

PMID:
11080707
35.

Determinants of patient satisfaction with migraine therapy.

Davies GM, Santanello N, Lipton R.

Cephalalgia. 2000 Jul;20(6):554-60.

PMID:
11075838
36.

Trends in persistent proteinuria in adult-onset diabetes: a population-based study.

Larson TS, Santanello N, Shahinfar S, O'Brien PC, Palumbo PJ, Melton LJ 3rd, Leibson CL.

Diabetes Care. 2000 Jan;23(1):51-6.

37.

The migraine work and productivity loss questionnaire: concepts and design.

Lerner DJ, Amick BC 3rd, Malspeis S, Rogers WH, Santanello NC, Gerth WC, Lipton RB.

Qual Life Res. 1999 Dec;8(8):699-710.

PMID:
10855344
38.

What are minimal important changes for asthma measures in a clinical trial?

Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL.

Eur Respir J. 1999 Jul;14(1):23-7.

39.

Validation of a migraine work and productivity loss questionnaire for use in migraine studies.

Davies GM, Santanello N, Gerth W, Lerner D, Block GA.

Cephalalgia. 1999 Jun;19(5):497-502.

PMID:
10403065
40.

Validation of an asthma symptom diary for interventional studies.

Santanello NC, Davies G, Galant SP, Pedinoff A, Sveum R, Seltzer J, Seidenberg BC, Knorr BA.

Arch Dis Child. 1999 May;80(5):414-20.

41.

Sex differences in the use of asthma drugs: cross sectional study.

Sexton M, Althuis MD, Santanello N, Hyndman S, Williams R, Schmeidler D.

BMJ. 1998 Nov 21;317(7170):1434-7.

42.

Cholesterol reduction yields clinical benefit: impact of statin trials.

Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD.

Circulation. 1998 Mar 17;97(10):946-52.

PMID:
9529261
43.

Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.

Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD.

Cephalalgia. 1997 Dec;17(8):867-72; discussion 800.

PMID:
9453276
44.

Measurement characteristics of two asthma symptom diary scales for use in clinical trials.

Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J.

Eur Respir J. 1997 Mar;10(3):646-51.

45.

The association of nocturnal asthma with asthma severity.

Fix A, Sexton M, Langenberg P, Santanello N, Hyndman S, Williams R.

J Asthma. 1997;34(4):329-36.

PMID:
9250257
46.

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

Santanello NC, Barber BL, Applegate WB, Elam J, Curtis C, Hunninghake DB, Gordon DJ.

J Am Geriatr Soc. 1997 Jan;45(1):8-14.

PMID:
8994481
47.
48.

Impact of the global on patient perceivable change in an asthma specific QOL questionnaire.

Barber BL, Santanello NC, Epstein RS.

Qual Life Res. 1996 Feb;5(1):117-22.

PMID:
8901374
49.

Relating spontaneous adverse experience reports to scores on a questionnaire querying tolerability.

Barber BL, Santanello NC.

Int J Clin Pharmacol Ther. 1995 Nov;33(11):598-604.

PMID:
8688984
50.

Validation of a new quality of life questionnaire for acute migraine headache.

Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD.

Headache. 1995 Jun;35(6):330-7.

PMID:
7635718

Supplemental Content

Loading ...
Support Center